Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
CR Sanjiu Pharma Acquires Shenghuo Pharma for $280 Million | July 27, 2016
Luye Pharma to Acquire Swiss Patch Drug Assets for $269 Million | July 26, 2016
Management Offers $228 Million to Privatize Concord Medical | July 11, 2016
China Resources Pharma Files for $1 Billion IPO in Hong Kong | June 29, 2016>> See all top stories...
ChinaBio® in the News